Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.65 |
| ▸ | GAA | P10253 | 5/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.63 |
| ▸ | TP53 | P04637 | 1/20 | 0.63 |
| ▸ | APP | P05067 | 1/20 | 0.63 |
| ▸ | HPGD | P15428 | 1/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.63 |
| ▸ | SNCA | P37840 | 1/20 | 0.63 |
| ▸ | BLM | P54132 | 1/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.62 |
| ▸ | MEN1 | O00255 | 3/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30323778 | 1.00 | MAPT (0.65) | MAPTGAATDP1KDM4ESMN1; SMN2 | |
| SCHEMBL6656632 | 0.88 | MAPK13 (0.73) | MAPTGAATDP1KDM4ESMN1; SMN2 | |
| SCHEMBL17546531 | 0.86 | AKR1C3 (0.45) | MAPTGAATDP1KDM4ESMN1; SMN2 | |
| SCHEMBL4607773 | 0.84 | MAPT (0.86) | MAPTGAATDP1KDM4ESMN1; SMN2 | |
| SCHEMBL24988399 | 0.84 | MAPT (0.57) | MAPTGAATDP1KDM4ESMN1; SMN2 | |
| SCHEMBL29824523 | 0.81 | MAPT (0.68) | MAPTGAATDP1KDM4ESMN1; SMN2 | |
| SCHEMBL15875869 | 0.81 | MAPT (0.68) | MAPTGAATDP1KDM4ESMN1; SMN2 | |
| SCHEMBL9703296 | 0.79 | P2RY1 (0.42) | MAPTGAATDP1KDM4ESMN1; SMN2 | |
| SCHEMBL4901952 | 0.79 | P2RX7 (0.46) | MAPTGAATDP1SMN1; SMN2TP53 | |
| SCHEMBL6290887 | 0.79 | MAPT (0.59) | MAPTGAATDP1KDM4ESMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230118772-A1 | ORGANOMETALLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-04-20 | — | — | US | disclosed |
| CN-107011268-B | The 1,3,6,8- tetra- of bipolarity D- π-A configuration replaces pyrenyl material and preparation method and application | 中国矿业大学 | 2019-07-23 | — | — | CN | disclosed |
| CN-106905242-B | The two poles of the earth configuration pyrenyl containing benzimidazole unit blue light material and preparation method and application | 中国矿业大学 | 2019-07-12 | — | — | CN | disclosed |
| CN-107011268-A | The 1,3,6,8 4 substitution pyrenyl materials and preparation method and application of bipolarity D π A configurations | 中国矿业大学 | 2017-08-04 | — | — | CN | disclosed |
| CN-106905242-A | The two poles of the earth configuration pyrenyl containing benzimidazole unit blue light material and preparation method and application | 中国矿业大学 | 2017-06-30 | — | — | CN | disclosed |
| US-8785002-B1 | High-energy triplet host materials, luminescent layer comprising the same, and organic electroluminescent device comprising the luminescent layer | BOWLING GREEN STATE UNIVERSITY (US) | 2014-07-22 | — | — | US | disclosed |
| US-8785002-B1 | High-energy triplet host materials, luminescent layer comprising the same, and organic electroluminescent device comprising the luminescent layer | BOWLING GREEN STATE UNIVERSITY (US) | 2014-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230118772-A1 | ORGANOMETALLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE | LAGE3, LIG1, AP1M1 | MAPT 1261/4885GAA 2695/4885TDP1 3068/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.